Log in to search using one of your social media accounts:

 

Tackling an Invasive, Emerging, Multi-Drug Resistant Yeast: Candida Auris - What Healthcare Providers Need to Know
Centers for Disease Control and Prevention. 08/15/2017 This one-hour webinar describes the epidemiology of Candida auris (C. auris), an emerging multi-drug-resistant fungus that can cause invasive infections with high mortality, and has been associated with outbreaks in healthcare settings. It explains the guidance for diagnosis and treatment of C. auris, and the infection control recommendations for containing C. auris. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - September 12, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

T2 Biosystems files 510(k) for T2Bacteria Panel
T2 Biosystems Inc. (NSDQ:TTOO) said today it filed a 510(k) appliation with the FDA for its T2Bateria Panel rapid diagnostic solution designed to identify pathogens assocaited with Sepsis. The T2Bacteria panel is designed to run on the FDA-cleared T2Dx instrument to provide diagnosis of sepsis pathogens within hours, reducing the time for patients with bloodstream infections to receive treatment, the Lexington, Mass.-based company said. The submission includes data from a pivotal clinical trial of the T2Bacteria Panel which compared it to blood culture, as well as the performance of the panel in known bacteria positiv...
Source: Mass Device - September 11, 2017 Category: Medical Devices Authors: Fink Densford Tags: Diagnostics Food & Drug Administration (FDA) Regulatory/Compliance T2 Biosystems Inc. Source Type: news

MassDevice.com +5 | The top 5 medtech stories for September 7, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Heraeus Medical Components acquires Biotectix Heraeus Medical Components is acquiring conductive polymer materials maker Biotectix. The deal, announced yesterday, will allow Heraeus to boost its medical electrode coating capabil...
Source: Mass Device - September 7, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

CDC to use T2 Biosystems in testing for superbug Candida auris
T2 Biosystems Inc. (NSDQ:TTOO) said today that the US Centers for Disease Control and Prevention will use its T2Dx Instrument to test and monitor for the emergence and outbreaks of the antibiotic-resistant superbug Candida auris. The Lexington, Mass.-based company said the use of the T2Dx “represents multiple, new applications” for the platform. The system will be used for the 1st time to test patient skin and blood samples and also for environmental surveillance and to monitor outbreaks. Both applications are currently available as research tools for investigational purposes in the US and Europe, T2 Biosy...
Source: Mass Device - September 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics T2 Biosystems Inc. Source Type: news

Candida cleanse diet: What does it treat?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - September 6, 2017 Category: Consumer Health News Source Type: news

Candida Auris: A New Fungal Superbug Emerging As A Global Threat
For the first time, a new yeast, Candida auris, is found to be spreading from person to person in hospitals. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 24, 2017 Category: Pharmaceuticals Authors: Judy Stone, Contributor Tags: NYSE:PFE NYSE:MRK Source Type: news

The Unexpected and Troubling Rise of Candida auris The Unexpected and Troubling Rise of Candida auris
Behaving like a multidrug-resistant microbe, C auris is spreading rapidly throughout the world, including in healthcare facilities in the United States.CDC Expert Commentary (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 24, 2017 Category: Consumer Health News Tags: Infectious Diseases Commentary Source Type: news

IBS warning: Bloating and stomach pain could actually be too much of THIS
IBS - or irritable bowel syndrome - is a common digestive condition causing stomach pain and bloating. However, symptoms could actually be triggered by an overgrowth of a yeast called candida. (Source: Daily Express - Health)
Source: Daily Express - Health - August 22, 2017 Category: Consumer Health News Source Type: news

Trust distances itself from staffing link to fungus outbreak
A major London hospital trust has sought to distance itself from suggestions that a lack of nursing staff was implicit in an outbreak of the so-called “Japanese fungus” infection Candida auris. (Source: Nursing Times)
Source: Nursing Times - August 17, 2017 Category: Nursing Source Type: news

Lack of nurses blamed for the spread of Japanese fungus
King's College Hospital in South London was responsible for 31 cases of Candida auris fungus infections during a year-long outbreak, figures show. Bosses at its trust blamed a lack of nurses. (Source: the Mail online | Health)
Source: the Mail online | Health - August 16, 2017 Category: Consumer Health News Source Type: news

Tackling an Invasive, Emerging, Multi-drug Resistant Yeast: Candida auris - What Healthcare Providers Need to Know
August 15, 2017 2:00-3:00pm ET. (Source: HSR Information Central)
Source: HSR Information Central - August 11, 2017 Category: International Medicine & Public Health Source Type: news

Saliva 'may speed healing' but 'kissing it better' probably won't
Conclusion This complex study helps us understand the biological mechanisms behind wound healing in the mouth and the role of saliva in promoting wound healing. As well as keeping the mouth moist and reducing levels of harmful bacteria, saliva contains a protein that encourages the movement of cells in ways that help wounds to heal. It's possible this might lead to the development of new wound-healing treatments in future; however, this study didn't look at future uses – it simply helps us better understand how the body heals itself. Before any new treatment could be developed, further studies in cell lines and in an...
Source: NHS News Feed - August 10, 2017 Category: Consumer Health News Tags: Pregnancy/child Source Type: news

Effect of Split-File Digital Workflow on Crown Margin Adaptation
Explore this journal>Early ViewPrevious article in Early View: Impact of Denture Cleansing Solution Immersion on Some Properties of Different Denture Base Materials: An In Vitro StudyNext article in Early View: Nicotine Upregulates Coaggregation of Candida albicans and Streptococcus mutans Browse  Early View ArticlesOnline Version of Record published before inclusion in an issueFirst published:9 June 2017Full publication historyDOI:10.1111/jopr.12606 View/save citationCited by (CrossRef):0 articles Check for updatesAbstractPurposeComputer-aided design/computer-aided manufacturing (CAD/...
Source: Dental Technology Blog - June 28, 2017 Category: Dentistry Source Type: news

Scary, infectious SUPERBUG just spread to five more U.S. states, including some in the Midwest
(Natural News) A deadly, hard-to-spot “superbug” yeast is rapidly infiltrating American hospitals. In June 2016, the U.S. Centers for Disease Control and Prevention (CDC) warned clinics about the emergence of a new multidrug-resistant yeast strain called Candida auris. Two months later the first seven cases of a C. auris infection were recorded in the United... (Source: NaturalNews.com)
Source: NaturalNews.com - June 21, 2017 Category: Consumer Health News Source Type: news

Single fungus amplifies Crohn's disease symptoms
(Case Western Reserve University) A microscopic fungus called Candida tropicalis triggered gut inflammation and exacerbated symptoms of Crohn's disease, in a recent study conducted at Case Western Reserve University School of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 21, 2017 Category: International Medicine & Public Health Source Type: news

In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida.
Ann Clin Microbiol Antimicrob. 2013 Dec 5;12:37. doi: 10.1186/1476-0711-12-37.In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida.Qiao J, Gao P, Jiang X, Fang H.BACKGROUND:Protein farnesylation is an important tosttranslational modification in fungi. We evaluated the antifungal activity of two farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - June 20, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida.
BACKGROUND:Protein farnesylation is an important posttranslational modification in fungi. We evaluated the antifungal activity of two farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida.METHODS:Disk diffusion assay and broth microdilution assay were used to determine the antifungal susceptibility of two farnesyltransferase inhibitors (manumycin A and tipifarnib) against clinical isolates of Aspergillus and Candida. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - June 20, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Candida auris for the Clinical Microbiology Laboratory: Not Your Grandfather's Candida Species
Candida auris is a newly emerging species that was first identified in Asia in 2009 but has rapidly spread across the world. C. auris differs from most other Candida species in that antifungal resistance is the norm rather than the exception, it is a commensal of human skin rather than the human gut, and it can be easily transmitted from person to person in a health care setting. This review discusses the emergence of C. auris, global epidemiology, identification, antifungal susceptibility testing, and precautions to be taken when it is identified from a patient specimen. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - June 20, 2017 Category: Microbiology Authors: Shawn R. Lockhart, Elizabeth L. Berkow, Nancy Chow, Rory M. Welsh Source Type: news

Transmission of Candida auris in US Health Care Facilities Transmission of Candida auris in US Health Care Facilities
This report details the epidemiology of the first seven U.S. cases of infection with the emerging, and often multidrug-resistant, fungus Candida auris.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 9, 2017 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

An Open Letter To Gwyneth Paltrow About GOOP
Dear Ms. Paltrow, I understand you recently said that anyone who is going to f*ck with you better bring their A game.   I’m pretty sure you don’t mean comment on your recipes but rather the growing exasperation from medical professionals and journalists alike at the almost constant debunking of the health “advice” and all around medical bullshit that you and your pals at GOOP promote and sell. No, we don’t have adrenal fatigue we have goopitis. When I tell you that alcohol is a toxin I am not f*cking with you I am being factual. Do you really think everything in the world is a toxin exce...
Source: Healthy Living - The Huffington Post - June 1, 2017 Category: Consumer Health News Source Type: news

The scariest superbug on the CDC's radar has hit 7 states
The spread of Candida auris started in New York and New Jersey - but in the last month, new infections have been spotted in  Illinois, Indiana, Maryland, Massachusetts and Oklahoma. (Source: the Mail online | Health)
Source: the Mail online | Health - May 19, 2017 Category: Consumer Health News Source Type: news

Candida Auris, Often Drug-Resistant, Found in 7 States (FREE)
By Amy Orciari Herman Edited by Andr é Sofair, MD, MPH, and William E. Chavey, MD, MS As of mid-May 2017, a total of 77 clinical cases of Candida auris in U.S. health care facilities were reported to the CDC, according to … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 19, 2017 Category: Primary Care Source Type: news

Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities — United States, June 2016–May 2017
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - May 18, 2017 Category: American Health Source Type: news

Candida auris: Emerging, Frequently Resistant, and Often Deadly Candida auris: Emerging, Frequently Resistant, and Often Deadly
Given frequent multidrug resistance, what drug therapy is appropriate for treating Candida auris?Medscape Pharmacists (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2017 Category: Consumer Health News Tags: Pharmacist Ask the Expert Source Type: news

Superbug FUNGUS now invading U.S. hospitals in NY and NJ ... All pharma drugs useless (but they refuse to use oregano oil)
(Natural News) The deadly superbug fungus known as Candida auris has continued to spread rapidly through hospitals in the U.S., mainly in the states of New York and New Jersey. When we last reported on the outbreak in March, there were 35 confirmed cases of the disease, 28 of them located in New York State.... (Source: NaturalNews.com)
Source: NaturalNews.com - May 10, 2017 Category: Consumer Health News Source Type: news

'Superbug' Fungus Outbreak in NY, NJ Hospitals
NEW YORK (AP) — A 'superbug' fungus is emerging as a new menace in U.S. hospitals, mostly in New York and New Jersey. First identified in Japan in 2009, the fungus has spread to more than a dozen countries around the globe. The oldest of the 66 cases reported in the U.S. dates back to 2013, but most were reported in the last year. The fungus called Candida auris is a harmful form of yeast. Scientists say it can be hard to identify with standard lab tests. U.S. health officials sounded alarms last year because two of the three kinds of commonly used antifungal drugs have little effect. "It's acting like a superbu...
Source: JEMS Patient Care - April 28, 2017 Category: Emergency Medicine Authors: Mike Stobbe,  AP Medical Writer Tags: News Patient Care Source Type: news

'Superbug' Fungus Outbreak in NY, NJ Hospitals
NEW YORK (AP) — A 'superbug' fungus is emerging as a new menace in U.S. hospitals, mostly in New York and New Jersey. First identified in Japan in 2009, the fungus has spread to more than a dozen countries around the globe. The oldest of the 66 cases reported in the U.S. dates back to 2013, but most were reported in the last year. The fungus called Candida auris is a harmful form of yeast. Scientists say it can be hard to identify with standard lab tests. U.S. health officials sounded alarms last year because two of the three kinds of commonly used antifungal drugs have little effect. "It's acting like a superbu...
Source: JEMS: Journal of Emergency Medical Services News - April 28, 2017 Category: Emergency Medicine Authors: Mike Stobbe,  AP Medical Writer Tags: News Patient Care Source Type: news

The scariest superbug on CDC's radar is a deadly fungus
Public health officials have revealed that a superbug - Candida auris, a harmful yeast - is on the CDC's radar after spreading to US hospitals, particularly in New York and New Jersey. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2017 Category: Consumer Health News Source Type: news

Your NEJM Group Today: Candida Esophagitis Images / New Approach to Hot Flashes? / FDA Medical Officer Opportunities (FREE)
By the Editors Here's what we chose for you from NEJM Group today:NEJM Clinical Practice Center: Image in Clinical Medicine: A 72-year-old man who … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 26, 2017 Category: Primary Care Source Type: news

Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.
Vulvovaginal candidiasis/candidosis is a common fungal infection afflicting approximately 75% of women globally caused primarily by the yeast Candida albicans. Fluconazole is widely regarded as the antifungal drug of choice since its introduction in 1990 due to its high oral bioavailability, convenient dosing regimen and favourable safety profile. However, its widespread use has led to the emergence of fluconazole-resistant C. albicans, posing a universal clinical concern. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Candin (Candida Albicans) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 11, 2017 Category: Drugs & Pharmacology Source Type: news

Candida auris Further Differentiated: Possible Therapies? Candida auris Further Differentiated: Possible Therapies?
The emerging C auris fungal pathogen is often multidrug resistant and hard to eradicate, but early data suggest it may respond to a new experimental drug.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 31, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis.
SCY-078 (MK-3118) is a novel, semisynthetic derivative of enfumafungin and represents the first compound of the triterpene class of antifungals. SCY-078 exhibits potent inhibition of β-(1,3)-d-glucan synthesis, an essential cell wall component of many pathogenic fungi, including Candida spp. and Aspergillus spp. SCY-078 is currently in phase 2 clinical development for the treatment of invasive fungal diseases. In vitro disposition studies to assess solubility, intestinal permea bility, and metabolic stability were predictive of good oral bioavailability. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - March 27, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Pharmacokinetics of the Novel Echinocandin, CD101, in Multiple Animal Species.
CD101 is a novel semisynthetic echinocandin with antifungal activity against Candida and Aspergillus spp. The pharmacokinetics (PK) of CD101 administered intravenously to mice, rats, dogs, cynomolgus monkeys, and chimpanzees are presented. CD101 consistently exhibited very low clearance, a modest volume of distribution at steady state (Vss), and a long half-life (t1/2) across all species tested. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - March 27, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Drug-Resistant Fungus Spreads Among U.S. Healthcare Facilities
This article was updated from a Nov. 2016 story on C. auris.  This reporting is brought to you by HuffPost’s health and science platform, The Scope. Like us on Facebook and Twitter and tell us your story: scopestories@huffingtonpost.com.    -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - March 21, 2017 Category: Consumer Health News Source Type: news

Hospitals in New York State are witnessing a deadly drug resistant fungal infection outbreak
(Natural News) More than 30 cases of infection from a deadly fungal superbug have now been confirmed in the United States, with 28 of the 35 reported cases occurring in hospitals located in New York State. Last year, health officials warned that cases of the highly drug-resistant fungus, Candida auris, might soon appear in the... (Source: NaturalNews.com)
Source: NaturalNews.com - March 21, 2017 Category: Consumer Health News Source Type: news

Candida solutions – The science behind the cure
(Natural News) Under normal circumstances, the Candida albicans yeast organism is a harmless – even beneficial – microbe that exists in the digestive tract. But when this tiny yeast cell is converted to its fungal form, over 120 different illnesses can be triggered – ranging from annoying (minor) conditions to life-threatening diseases.  According to Dr.... (Source: NaturalNews.com)
Source: NaturalNews.com - March 1, 2017 Category: Consumer Health News Source Type: news

First systematic study of deadly, antibiotic-resistant fungus reported
The deadly fungus, Candida auris, which has been found in hospitals, is resistant to entire classes of antimicrobial drugs, limiting treatment options for those infected. Microbiologists have provided previously uninvestigated details pertaining to C. auris drug resistance and growth patterns. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 24, 2017 Category: Science Source Type: news

110-Year-Old Nun's Secret To Long A Life Is Pretty Simple
One of the world’s oldest women says the key to a long life is love ― but for Sister Candida Bellotti that doesn’t mean the romantic kind. Bellotti celebrated her 110th birthday on Monday surrounded by fellow sisters from her order. Her advice for a long life? “Love, love and keep on loving. With joy!” the centenarian told journalists gathered for the special occasion at her Tuscan convent. “Have faith in the future, and put in as much work as you can to make your wishes come true,” she added. Bellotti was born on Feb. 20, 1907 in Verona, Italy. She became a nun with the Ministre ...
Source: Healthy Living - The Huffington Post - February 22, 2017 Category: Consumer Health News Source Type: news

Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults.
CD101 IV is a novel echinocandin with distinctive pharmacokinetic properties that is being developed as a once-weekly treatment for candidemia and invasive candidiasis. CD101 has potent in vitro activity and in vivo efficacy against a broad range of Candida and Aspergillus species. The primary objective of two randomized, double-blind, placebo-controlled, dose-escalation studies in healthy adults was to determine the safety and tolerability of CD101 IV. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - January 23, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Chlorhexidine Effective Against Candida auris Biofilms Chlorhexidine Effective Against Candida auris Biofilms
A combination of standard infection-prevention measures and the use of the disinfectant chlorhexidine should be used to control the spread of C auris in hospital environments, a new study has shown.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 12, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Candida auris: Time to Prick Up Your Ears? Candida auris: Time to Prick Up Your Ears?
Candida auris: Have you heard of it yet? Dr Auwaerter discusses this newly identified and potentially drug-resistant isolate and tells clinicians to be on the lookout.Medscape Infectious Diseases (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - December 15, 2016 Category: Infectious Diseases Tags: Infectious Diseases Commentary Source Type: news

THRUSH breakthrough: Potentially deadly fungus plays 'hide-and-seek' from immune system
THRUSH is a common fungal infection caused by a fungus which called candida albicans. While the fungus is relatively harmless most of the time - it can be deadly in patients with weakened immune systems. (Source: Daily Express - Health)
Source: Daily Express - Health - December 12, 2016 Category: Consumer Health News Source Type: news

Stealth fungus that causes thrush'hides' from immune system
Experts from the MRC Centre for Medical Mycology at the University of Aberdeen have discovered how the fungus which causes thrush tries to hide from our body’s defences. Candida albicans can be deadly when it takes advantage of the weakened immune systems of cancer or transplant patients. (Source: Medical Research Council General News)
Source: Medical Research Council General News - December 12, 2016 Category: Research Source Type: news

Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure : The EMPIRICUS Randomized Clinical Trial
This randomized clinical trial has lead to a practice changing update on Dynamed Plus. It compares the effects of micafungin vs placebo on 28-day fungal infection –free survival among nonneutropenic critically ill patients with ICU-acquired sepsis, Candida species colonization at multiple sites, and multiple organ failure. It concludes that empiric micafungin does not improve 28-day fungal infection-free survival in nonneutropenic patients with ICU-acquired sepsis. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 2, 2016 Category: Consumer Health News Source Type: news

First Reported Cases of Candida auris in the US First Reported Cases of Candida auris in the US
Candida auris, an emerging multi-drug resistant and highly pathogenic fungus, has been previously reported from at least a dozen countries. What are the characteristics of the first US cases?Morbidity & Mortality Weekly Report (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - December 2, 2016 Category: Transplant Surgery Tags: Infectious Diseases Journal Article Source Type: news

What The Latest Research Really Means For Crohn’s Disease
A recent study came out this month identifying specific fungus and bacteria that were linked to cases of Crohn’s disease. While E coli had previously been identified, this new study finds Serratia marcescens and candida tropicalis are in the mix as well (1). Crohn’s disease affects more than a half-million people each year inflicting debilitating symptoms such as chronic diarrhea, abdominal pain, weight loss and fatigue. Researchers were pleased to present this new information in the hopes of leading to better treatment options for patients down the road. While this study sheds light on possible aberrations of ...
Source: Science - The Huffington Post - November 30, 2016 Category: Science Source Type: news

Study reveals workings of immune response to deadly fungal infections
(Brown University) Now that scientists understand what triggers key steps in the immune response to menacing fungi such as Candida albicans, they hope to develop ways to make it work better. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 17, 2016 Category: Infectious Diseases Source Type: news

Drug-resistant < i > Candida auris < /i > Reported in United States
The CDC has identified 13 cases ofCandida auris infection in the United States to date, detailing the first seven of them in aMorbidity and Mortality Weekly Report posted Nov. 4. (Source: AAFP News)
Source: AAFP News - November 15, 2016 Category: Primary Care Source Type: news

Oral Thrush - What Bumps on Your Tongue May Be Telling You
Stick your tongue out and look in the mirror. A healthy tongue should be pink and slightly red, and covered with tiny nodules. An appearance with a white coating or bumps on the tongue are a deviation from your tongue's normal appearance and may be cause for concern. A minor infection on the tongue isn't uncommon. Bumps may even appear after an injury from a bite or irritation to some foods, for example hot foods. A canker sore is another common cause of pain on or under the tongue. But if you have large bumps at the back of your tongue, and a coating of white on your tongue it may be a sign of Oral Thrush. Oral thrush...
Source: Healthy Living - The Huffington Post - November 14, 2016 Category: Consumer Health News Source Type: news